'COVAXIN is safe and protects against COVID-19' - The Lancet
Interim data from a phase 3 trial of Bharat Biotech's Covaxin show that two doses offer 77.8% protection against symptomatic Covid. The findings have been published in The Lancet. @MoHFW_INDIA
@mansukhmandviya pic.twitter.com/9lR2R0SS69— Prasar Bharati News Services पी.बी.एन.एस. (@PBNS_India) November 12, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


